Bloomberg Television
Bloomberg Television
@markets·3.2M subscribers·95.6K videos

China's Wuxi Biologics Working on Programs for Covid-19 Virus: CEO

Posted

April 13, 2020

Views

86,638

Likes

325

Comments

672

Engagement

1.15%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Apr.12 -- Chris Chen, chief executive officer of Wuxi Biologics (Cayman) Inc., a pharmaceutical company developing and manufacturing antibody drugs, discusses how the coronavirus outbreak has been affecting his business, and the company's programs related to the Covid-19 virus. He speaks with Haslinda Amin and Rishaad Salamat on "Bloomberg Markets: Asia."

Guests & Subjects Covered

Chris ChenWuxi Biologics Cayman IncHaslinda AminRishaad SalamatBloomberg Markets Asia

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

China's Wuxi Biologics Working on Programs for Covid-19 Virus: CEO · Bloomberg Television · Sentinel